Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

53.84
+0.18000.34%
Volume:1.58M
Turnover:84.69M
Market Cap:4.31B
PE:-14.24
High:53.87
Open:53.67
Low:53.63
Close:53.66
52wk High:58.40
52wk Low:21.34
Shares:79.99M
Float Shares:67.77M
Volume Ratio:0.33
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7801
EPS(LYR):-3.7544
ROE:-31.14%
ROA:-20.36%
PB:4.20
PE(LYR):-14.34

Loading ...

Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 14, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 26, 2021

Major Issues Report

8-K - Current report
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Major Issues Report

8-K - Current report